and EHCP5) are missing in E. dispar. 8 In this study, we attempted to explore genetic encoding differences of CP5 of E. histolytica in its various infectious properties in East Azerbaijan as opposed to those of tropical areas in relevance to the possibility of genetic polymorphism of this parasite in these 2 geographic areas.
Materials and Methods
Subjects were selected from infected persons in 2 geographic areas, Tabriz for cold regions and Bandar Abbas for tropical regions, during [2005] [2006] . This study was performed in 3 distinct stages: collection of samples, culture of samples, molecular preparation and evaluation. 1. Collection of samples: A total of 2332 stool samples (1550 from Tabriz and 782 from Bandar Abbas) were randomly collected from patients referred to local hospital or laboratory of public health center located in East Azerbaijan and Bandar Abbas. The direct examination and formalin ether concentration method were used for detection of E. histolytica/E. dispar trophozoite or cyst, respectively. 2. Culture and preservation: Coagulated horse serum medium was used to transform cysts to trophozoites for culturing positive samples. Then Robinson culture medium was used for mass culture and the adaptation of trophozoites. 9, 10 3. Preparation and molecular study: After 3-4 subcultures, the upper layer of Robinson medium was removed and the deposit was kept in centrifuge tube. Then 10 mL of PBS solution with pH:7.2 was added to the tube and mixed adequately twice at 1600 rpm for 5 minutes using centrifugation. The upper layer was removed and deposit was mixed with 10 mL of PBS suspension and centrifuged again. The sediment was then suspended in 1 mL of PBS and finally divided equally in 1.5 mL Eppendorf tubes and kept at -80°C until DNA extraction.
Method of DNA Extraction From Trophozoites
DNA extraction was performed according to the phenolchloroform method described by Sambrook et al with a slight modification.
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DNA Extraction From the Cyst DNA extraction from the cyst was carried out using the QIAamp stool Mini Kit.
Design of Primers
Since there is not CP5 gene in E. dispar, specific primers from highly conserved regions of CP5 gene was designed by investigation of GenBank. The primer could differentiate E. histolytica from E. dispar through the observation of a 950-bp band only for E. histolytica.
Target DNA Amplification by Polymerase Chain Reaction Polymerase chain reaction (PCR) amplification of the 950-bp fragment of the CP5 gene was performed on DNA from the positive clinical samples. Amplification of the CP5 gene was performed as a single PCR with specifically designed primers as follows: 5' GTT CACTGTCTCGTTATTAG 3' as forward and 5' CATCAGCAACCCCAACTG 3' as reverse. The primers were tested by standard E. histolytica (HM1 strain) and E. dispar (AS16IR) DNA. The PCR reaction mixture consisted of 3 μL of template DNA, 10 μL of 10X PCR buffer (Roche), 0.2 mM of each deoxynucleoside triphosphate (dNTPs), 3 μL of MgCl2 50 mM, 1 U of Taq DNA polymerase (CinnaGen, Tehran, Iran), and 20 picomol of each primer, and 30 μL of distilled water.
DNA was amplified using Primus, MWG-BIOTECH, Thermal Cycler under the following conditions: 5 minutes at 95°C as an initial hot start step, followed by 35 cycles of 1 minute at 95°C, 2 minutes at 46°C, 3 seconds at 72°C, and 10 minutes at 72°C as the final extension step. Distilled water was used as negative control. The PCR products were electrophoresized on ethidium bromidestaining 1% (W/V) agarose gel. In the case of detection of a banding pattern with approximate size of 950 bp, it was considered as E. histolytica and sequencing of PCR fragments were then performed. This process was done for 10 samples from each mentioned area.
. Results Microscopic examination of 2332 stool samples (1550 from Tabriz and 782 from Bandar Abbas) showed that a total of 148 samples (6.35%) were positive for E. histolytica/E. dispar (65 specimens from Tabriz and 83 specimens from Bandar Abbas). PCR amplification of the 950 bp fragment of the CP5 gene was performed on DNA from clinical samples diagnosed with E. histolytica/E. dispar. We characterized CP5 gene in E. histolytica isolates by observation of the 950 bp band after electrophoresis of PCR product (Figure 1) .
In order to sequence the isolates, 20 positive samples for E. histolytica (10 positive samples from each region) were selected. The PCR products were sequenced on both strands and multiple alignment was produced (Figure 2) . Results of the sequencing analysis of the products were obtained from E. histolytica by CP5-PCR, matched with GenBank data. A summary of these results is shown in Figure 2 . . compared to those from Tabriz. The nucleotide and deduced amino acid sequences of the CP5 gene of 2 isolates of E. histolytica from the south (Bandar Abbas) and the northwest (Tabriz) of Iran was submitted to the GenBank (NCBI) and would be released for public access under the numbers: DQ899178, DQ899179.
Protein analysis was also performed and the result revealed some substitutions as follows (Figure 3) 15 and PCR based assays 9, 16 have shown to be successful in identifying and differentiating these amoebas.
One of the significant factors as a best target is infectious elements as well as differentiating factors between pathogenic and non-pathogenic E. histolytica. 3 Cysteine proteinase is the most important pathogenicity factor of E. histolytica. This enzyme has been recognized in many organisms including parasites, bacteria, plants as well as vertebrate and invertebrate animals. 4 Que and Reed reported that extracellular release of cysteine proteinase in E. histolytica is 10-1000 fold more than that in noninvasive E. dispar. 3 Among several documented genes which encode cysteine proteinases in both species, only EHCP1 and EHCP5 are specific for E. histolytica.
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EHCP5 is also the most important pathogenicity factor in E. histolytica. 18 To the best of our knowledge, there was no study on the genetic polymorphism of CP5 gene and its sequences in different areas of Iran; therefore, the present study was developed to distinguish E. histolytica from E. dispar by single PCR using specific primer of CP5 gene. It was also studied the polymorphism of CP5 gene on E. histolytica isolated from 2 regions, Tabriz and Bandar Abbas.
In this study, amplification of the CP5 gene was performed as a single PCR and the 950 bp expected size fragment was amplified only in E. histolytica. The designed primers successfully allowed the discrimination of E. dispar from E, histolytica. In addition, the lack of CP5 gene in E. dispar was revealed which is in agreement with previous findings. 17 Hooshyar et al used PCR-RFLP method in order to differentiate E. histolytica from E. dispar in Iranian specimens. They used restriction enzymes for discrimination of 2 species on 101 isolates. They showed that 92.1% were E. dispar and only 7.9% were E. dispar and/or mixed infections. 9 In this study, among 2332 collected samples, 148 were distinguished as E. histolytica/dispar. Present research in comparison with previous studies 12, 13 clearly showed that the prevalence of E. histolytica/dispar in these geographic areas reduced, despite the fact that the prevalence is still higher in warmer climates. Decline of percentage of infected cases in comparison to past reported incidence is because of recent advances in diagnosis, increased education, and people awareness, and have been linked with efforts to improve sanitation and general health especially in rural communities.
Moreover, the amplification of CP5 gene and sequence analysis of 10 samples selected from Tabriz and 10 samples from the tropical region of Bandar Abbas were performed. Sequence analysis at the CP5 locus and comparison of these isolates with reference sequences in GeneBank showed variation in 7 SNPs and nucleotides substitution.
Protein analysis revealed some important substitutions as follows: the amino acid substitution in position 32 was shown and cysteine was replaced with tryptophan in 6 Bandar Abbas isolates, but the variation was seen in only 2 Tabriz isolates. It should also be noted that cysteine is fundamental for 3D structure of enzyme and consequently for its function.
The findings of our study indicated that amino acid variations in each section might change function of cysteine proteinase enzyme. As mentioned in the results, in position 232 there was valine instead of alanine (data not shown). This variation occurred in catalytic domain of CP5 gene of 6 isolates from Bandar Abbas and 2 isolates from Tabriz. It is possible that this type of variation may help the parasite to escape from immune system or resist to the drug.
The most variations were seen in polypeptides encoding CP5 of E. histolytica isolates from tropical region (Bandar Abbas). It seems that E. histolytica infection depends on the factors including protozoa habitat in human, age, sanitation level, and economic and social circumstances. Besides, various weather conditions in the tropical climate have lead to some variation in nucleotide and amino acid sequences and as a consequence, pathogenetic features have differed. This opinion is in agreement with the
